Comprehensive multidisciplinary programs for the management of patients with congestive heart failure

Journal of General Internal Medicine

Volumn 14, Issue 2, 1999, Pages 130-135

  Philbin, Edward F ^a  

^a HENRY FORD HOSPITAL   (United States)

Author keywords

Congestive heart failure; Disease management; Health care costs; Health services research; Quality improvement

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NITRATE; VASODILATOR AGENT; WARFARIN;

AEROBIC CAPACITY; CONGESTIVE HEART FAILURE; ECONOMICS; FUNCTIONAL ASSESSMENT; HEALTH CARE COST; HEALTH CARE UTILIZATION; HOSPITAL ADMISSION; HUMAN; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT MONITORING; PATIENT SATISFACTION; REVIEW;

AGED; COMPREHENSIVE HEALTH CARE; DISEASE MANAGEMENT; FEMALE; HEALTH SERVICES RESEARCH; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; PROGRAM DEVELOPMENT; SENSITIVITY AND SPECIFICITY; UNITED STATES;

EID: 0032972489     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1525-1497.1999.00291.x     Document Type: Review

References (44)

1. Captopril Multicenter Research Group. A placebo-controlled trial of refractory chronic congestive heart failure. J Am Coll Cardiol. 1983;2:755-63.
2. Packer M, Lee WH, Yushak M, Medina N. Comparison of captopril and enalapril in patients with severe chronic heart failure. N Engl J Med. 1986;315:847-53.
3. Kjekshus J, Swedberg K. Tolerability of enalapril in congestive heart failure. Am J Cardiol. 1988;62:A67-72.
4. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study. N Engl J Med. 1987;316:1429-35.
5. The SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med. 1991;325:293-302.
6. Rogers WJ, Johnstone DE, Yusuf S, et al. Quality of life among 5,025 patients with left ventricular dysfunction randomized between placebo and enalapril: the Studies of Left Ventricular Dysfunction. J Am Coll Cardiol. 1994;23:393-400.
7. Cohn JN, Johnson G, Zieshe S, et al. A comparison of enalapril with hydralazine-Isosorbide in the treatment of chronic congestive heart failure. N Engl J Med. 1991;325:303-10.
8. Pfeffer MA, Braunwald E, Moye LA, et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. N Engl J Med. 1992;327:669-77.
9. Philbin EF, Rocco TA. The utility of angiotensin-converting enzyme inhibitors in heart failure with preserved systolic function. Am Heart J. 1997;134:188-95.
10. Paul SD, Kuntz KM, Eagle KA, Weinstein NC. Costs and effectiveness of angiotensin converting enzyme inhibition in patients with congestive heart failure. Arch Intern Med. 1994;154:1143-9.
11. Konstam MA, Dracup K, Bottoroff MB, et al. Quick Reference Guide For Clinicians, No. 11: Heart Failure: Management of Patients with Left Ventricular Systolic Dysfunction. Rockville, Md: Agency for Health Care Policy and Research, Public Health Service, United States Department of Health and Human Services; 1994. AHCPR publication 94-0613.
12. Johnstone DE, Abdulla A, Arnold JMO, et al. Diagnosis and management of heart failure. Can J Cardiol. 1994; 10:613-31.
13. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N Engl J Med. 1997;336:525-33.
14. Philbin EF, Rocco TA, Cotto M, Jenkins PL. Association between attenuated diuretic response and death in acute heart failure. Am J Cardiol. 1997;80:519-22.
15. Packer M, Bristow MR, Cohn JN, et al. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N Engl J Med. 1996;334:1349-55.
16. Doval HC, Nul DR, Vancelli HO, Elizari M. Randomized trial of low-dose amiodarone in severe congestive heart failure. Lancet. 1994;344:493-8.
17. Costanzo MR, Augustine S, Bourge R, et al. Selection and treatment of candidates for heart transplantation: a statement for health professionals from the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association. Circulation. 1995;92:3593-612.
18. Killip T, Passamani E, Davis K. Coronary Artery Surgery Study (CASS): a randomized trial of coronary bypass surgery: eight years follow-up and survival in patients with reduced ejection fraction. Circulation. 1985;72(suppl V):V-102-9.
19. Smith W, McAnulty JH, Rahimtoola SH. Severe aortic stenosis with impaired left ventricular function and clinical heart failure: results of valve replacement. Circulation. 1978;58:258-64.
20. Moss AJ, Hall WJ, Cannom DS, et al. Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. N Engl J Med. 1996;335:1933-40.
21. Domanski MJ, Garg R, Yusuf S. Prognosis in congestive heart Failure. In: Hosenpud JD, Greenberg BH, eds. Congestive Heart Failure: Pathophysiology, Diagnosis and Comprehensive Approach to Management. New York, NY: Springer-Verlag; 1994:622-7.
22. Parmley W. Pathophysiology and current treatment of congestive heart failure. J Am Coll Cardiol. 1989;13:771-85.
23. Cardiology Preeminence Roundtable. Beyond Four Walls. Cost-Effective Management of Chronic Congestive Heart Failure. Washington, DC: The Advisory Board Company; 1994:39-47.
24. Krumholz HM, Parent EM, Tu N, et al. Readmission after hospitalization for congestive heart failure among Medicare beneficiaries. Arch Intern Med. 1997;157:99-104.
25. Philbin EF, DiSalvo TG. Managed care for congestive heart failure: influence of payer status on process of care, resource utilization and clinical outcomes. Am Heart J. 1998;136:553-61.
26. Philbin EF, Lynch LJ, Rocco TA, et al. Does quality improvement work? The Management to Improve Survival in Congestive Heart Failure (MISCHF) Study. Jt Comm J Qual Improv. 1996;22: 721-33.
27. O'Connell JB, Bristow MR. Economic impact of heart failure in the United States: time for a different approach. J Heart Lung Transplant. 1994;13:S107-12.
28. Philbin EF, Andreou C, Rocco TA, Lynch LJ, Baker SL. Patterns of anglotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals. Am J Cardiol. 1996;77:832-8.
29. Philbin EF. Factors determining angiotensin-converting enzyme inhibitor use in heart failure in the community setting. Clin Cardiol. 1998;21:103-8.
30. Ashton CM, Kuykendall DH, Johnson ML, Wray NP, Wu L. The association between the quality of inpatient care and early readmission. Ann Intern Med. 1995;122:415-21.
31. Philbin EF, Rocco TA, Lynch LJ, Rogers VA, Jenkins P. Predictors and determinants of hospital length of stay in congestive heart failure in ten community hospitals. J Heart Lung Transplant. 1997;16:548-55.
32. Weingarten S, Riedinger M, Conner L, Johnson B. Reducing lengths of stay in the coronary care unit with a practice guideline for patients with congestive heart failure: insights from a controlled clinical trial. Med Care. 1994;32:1232-43.
33. Fonarow GC, Stevenson LW, Walden JA, et al. Impact of a comprehensive heart failure management program on hospital readmission and functional status of patients with advanced heart failure. J Am Coll Cardiol. 1997;30:725-32.
34. Kornowski R, Zeelt D, Averbuch M, et al. Intensive home-care surveillance prevents hospitalization and improves morbidity among elderly patients with severe congestive heart failure. Am Heart J. 1995;129:762-6.
35. Rich MW, Beckman V, Wittenberg C, Leven CL, Freedland KE, Carney RM. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive heart failure. N Engl J Med. 1995;333:1190-5.
36. Shah NB, Der E, Ruggerio C, Heidenreich PA, Massie BM. Prevention of hospitalizations for heart failure with an interactive home monitoring program. Am Heart J. 1998;135:373-8.
37. Tilney CK, Whiting SB, Horrar JL, Perkins BD, Vance RP, Reeves JD. Improved clinical and financial outcomes associated with a comprehensive congestive heart failure program. Dis Manage. 1998; 1:175-83.
38. Weinberger M. Oddone EZ, Henderson WG. Does increased access to primary care reduce hospital readmissions? N Engl J Med. 1996;334:1441-7.
39. West JA, Miller NH, Parker KM, et al. A comprehensive management system for heart failure improves clinical outcomes and reduces medical resource utilization. Am J Cardiol. 1997;79:58-63.
40. Edep ME, Shah NB, Tateo IM, Massie BM. Differences between primary care physicians and cardiologists in management of congestive heart failure: relation to practice guidelines. J Am Coll Cardiol. 1997;30:518-26.
41. Reis SE, Holubkov R, Edmundowicz D, et al. Treatment of patients admitted to the hospital with congestive heart failure: specialty-related disparities in practice patterns and outcomes. J Am Coll Cardiol. 1997;30:733-8.
42. Philbin EF, Weil HF, Erb T. Outcomes In heart failure based on specialty care. Circulation. 1996; 94[8 suppl 11: I-50. Abstract.
43. Shah N, Edep M, Massie BM. Differences between cardiologists and heart failure specialists in the management of congestive heart failure. Circulation. 1995;92(suppl 1) I-666. Abstract.
44. Retchin SM, Brown B. Elderly patients with congestive heart failure under prepaid care. Am J Med. 1991;90:236-42.